# Exposure, D-Cycloserine Enhancement, and Genetic Modulators in Panic Disorder

> **NCT00790868** · PHASE2 · COMPLETED · sponsor: **Boston University Charles River Campus** · enrollment: 180 (actual)

## Conditions studied

- Panic Disorder

## Interventions

- **DRUG:** d-cycloserine
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00790868
- **Lead sponsor:** Boston University Charles River Campus
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2018-03-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00790868

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00790868, "Exposure, D-Cycloserine Enhancement, and Genetic Modulators in Panic Disorder". Retrieved via MORVS 2026-10-23 from https://api.morvs.ai/clinical/NCT00790868. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*